CXCL12 and neoplasm: CAF-derived CXCL12 is believed to promote T cell chemotaxis and sequester them within the peritumoral stroma, thereby restricting their infiltration into tumor nests, impairing effective antitumor immunity, and ultimately contributing to poor clinical outcomes7–9,25.